Aakriti Pandita, MD
About Aakriti Pandita, MD
Aakriti Pandita, MD, is an Assistant Professor at the University of Colorado, specializing in infectious diseases and internal medicine. She combines her expertise in medicine with a strong background in writing to humanize patient experiences and advocate for equity in healthcare.
Work at University of Colorado
Aakriti Pandita serves as an Assistant Professor at the University of Colorado since 2020. In this role, she engages in teaching and mentoring medical students and residents. Her work focuses on integrating storytelling into medical education to enhance understanding of patient experiences. This approach aims to shape public narratives around health and illness.
Education and Expertise
Aakriti Pandita is dual board-certified in infectious diseases and internal medicine. She specializes in managing complex infections, including tuberculosis (TB), HIV, and antibiotic resistance. Her educational background includes extensive training as an Internal Medicine Resident at State University of New York Upstate Medical University from 2014 to 2018, and as a Clinical Fellow at The Warren Alpert Medical School of Brown University from 2018 to 2020.
Background
Aakriti Pandita has a diverse background in medicine and writing. She worked as an Observer at Cleveland Clinic and as a Visiting Student at Memorial Sloan-Kettering Cancer Center in 2013. Her experiences in various medical settings have informed her approach to patient care and storytelling in medicine. She is also a member of the Lighthouse Writers Workshop since 2021.
Achievements
Aakriti Pandita has contributed to clinical and translational research in diseases such as tuberculosis, COVID-19, and leukemia. She was selected for the Book Project program, where she is developing a manuscript that combines storytelling with human experiences in medicine. Additionally, she is working on a digital tool aimed at advancing precision medicine.
Advocacy in Healthcare
Aakriti Pandita advocates for equity in healthcare, emphasizing the importance of representation for minority communities in clinical trials. Her commitment to addressing disparities in healthcare access and outcomes reflects her dedication to improving public health and patient care.